The University of California, San Francisco (UCSF) has been awarded a $675,175 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant will fund a 5-year, multicenter clinical trial titled "The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery: A Multicenter Pragmatic Cluster Cross-Over Randomized Trial (The VEGA-2 Trial)." The study aims to determine the optimal vasopressor agent, either norepinephrine or phenylephrine, to prevent postoperative acute kidney injury in patients undergoing major non-cardiac surgery. This research directly aligns with NIDDK's mission to prevent kidney disease and improve health outcomes in the surgical population.
Generated 3/18/25, 3:49 AM